Edwards Lifesciences (EW) PT Lowered to $250 but Cowen Sees Short Lull Before Recovery
Tweet Send to a Friend
Cowen analyst Joshua Jennings lowered the price target on Edwards Lifesciences (NYSE: EW) to $250.00 (from $275.00) on the belief ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
